Martin Pule

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 64% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Martin Pule's trades of Autolus Therapeutics PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
21.69
Quantity 97,704
Value US$3,374,146
Transaction date
Purchase
Price
283.92
Quantity 32,049
Value £1,528,656
Transaction date
Purchase
Price
146.33
Quantity 3,810
Value £1,367,909
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-09-16 2024-09-16 PrS Proposed sale
97,704
21.69
US$3,374,146
97,704 21.69 US$3,374,146
2023-07-19 2023-07-18 B Purchase
32,049
283.92
£1,528,656
32,049 283.92 £1,528,656
2022-10-25 2022-10-21 B Purchase
3,810
146.33
£1,367,909
3,810 146.33 £1,367,909